Medical - Care Facilities
Compare Stocks
2 / 10Stock Comparison
MCTA vs BTBT
Revenue, margins, valuation, and 5-year total return — side by side.
Financial - Capital Markets
MCTA vs BTBT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Care Facilities | Financial - Capital Markets |
| Market Cap | $445M | $589M |
| Revenue (TTM) | $6M | $164M |
| Net Income (TTM) | $1M | $137M |
| Gross Margin | 67.2% | 61.9% |
| Operating Margin | 22.3% | 16.8% |
| Forward P/E | 414.5x | 9.2x |
| Total Debt | $1M | $14M |
| Cash & Equiv. | $817K | $95M |
Quick Verdict: MCTA vs BTBT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
MCTA is the clearest fit if your priority is long-term compounding.
- 319.3% 10Y total return vs BTBT's -60.4%
- 19.3% margin vs BTBT's 17.3%
- +319.3% vs BTBT's -9.0%
BTBT carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.
- Rev growth 264.6%, EPS growth 225.0%
- Lower volatility, beta 3.37, Low D/E 3.0%, current ratio 5.39x
- Beta 3.37, yield 0.3%, current ratio 5.39x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 264.6% NII/revenue growth vs MCTA's 3.4% | |
| Value | Lower P/E (9.2x vs 414.5x) | |
| Quality / Margins | 19.3% margin vs BTBT's 17.3% | |
| Stability / Safety | Lower D/E ratio (3.0% vs 23.6%) | |
| Dividends | 0.3% yield; the other pay no meaningful dividend | |
| Momentum (1Y) | +319.3% vs BTBT's -9.0% | |
| Efficiency (ROA) | 23.4% ROA vs BTBT's 19.0%, ROIC 265.0% vs 6.5% |
MCTA vs BTBT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
MCTA vs BTBT — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
MCTA leads this category, winning 4 of 4 comparable metrics.
Income & Cash Flow (Last 12 Months)
BTBT is the larger business by revenue, generating $164M annually — 26.3x MCTA's $6M. Profitability is closely matched — net margins range from 19.3% (MCTA) to 17.3% (BTBT).
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $6M | $164M |
| EBITDAEarnings before interest/tax | — | $166M |
| Net IncomeAfter-tax profit | — | $137M |
| Free Cash FlowCash after capex | — | -$448M |
| Gross MarginGross profit ÷ Revenue | +67.2% | +61.9% |
| Operating MarginEBIT ÷ Revenue | +22.3% | +16.8% |
| Net MarginNet income ÷ Revenue | +19.3% | +17.3% |
| FCF MarginFCF ÷ Revenue | +2.2% | -65.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | — | +2.8% |
Valuation Metrics
BTBT leads this category, winning 4 of 4 comparable metrics.
Valuation Metrics
At 9.2x trailing earnings, BTBT trades at a 98% valuation discount to MCTA's 414.5x P/E. On an enterprise value basis, BTBT's 8.5x EV/EBITDA is more attractive than MCTA's 269.8x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $445M | $589M |
| Enterprise ValueMkt cap + debt − cash | $446M | $508M |
| Trailing P/EPrice ÷ TTM EPS | 414.55x | 9.15x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 269.80x | 8.49x |
| Price / SalesMarket cap ÷ Revenue | 71.60x | 3.60x |
| Price / BookPrice ÷ Book value/share | 9999.00x | 0.56x |
| Price / FCFMarket cap ÷ FCF | 3219.65x | — |
Profitability & Efficiency
MCTA leads this category, winning 5 of 7 comparable metrics.
Profitability & Efficiency
MCTA delivers a 24.4% return on equity — every $100 of shareholder capital generates $24 in annual profit, vs $21 for BTBT. BTBT carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to MCTA's 23.57x.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +24.4% | +21.4% |
| ROA (TTM)Return on assets | +23.4% | +19.0% |
| ROICReturn on invested capital | +2.6% | +6.5% |
| ROCEReturn on capital employed | +3.4% | +8.5% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 6 |
| Debt / EquityFinancial leverage | 23.57x | 0.03x |
| Net DebtTotal debt minus cash | $343,868 | -$81M |
| Cash & Equiv.Liquid assets | $816,771 | $95M |
| Total DebtShort + long-term debt | $1M | $14M |
| Interest CoverageEBIT ÷ Interest expense | 66.54x | — |
Total Returns (Dividends Reinvested)
MCTA leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MCTA five years ago would be worth $41,929 today (with dividends reinvested), compared to $1,543 for BTBT. Over the past 12 months, MCTA leads with a +319.3% total return vs BTBT's -9.0%. The 3-year compound annual growth rate (CAGR) favors MCTA at 61.3% vs BTBT's -7.1% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -0.0% | -10.3% |
| 1-Year ReturnPast 12 months | +319.3% | -9.0% |
| 3-Year ReturnCumulative with dividends | +319.3% | -19.7% |
| 5-Year ReturnCumulative with dividends | +319.3% | -84.6% |
| 10-Year ReturnCumulative with dividends | +319.3% | -60.4% |
| CAGR (3Y)Annualised 3-year return | +61.3% | -7.1% |
Risk & Volatility
MCTA leads this category, winning 1 of 1 comparable metric.
Risk & Volatility
MCTA currently trades 92.6% from its 52-week high vs BTBT's 40.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | — | 3.37x |
| 52-Week HighHighest price in past year | $31.70 | $4.55 |
| 52-Week LowLowest price in past year | $4.30 | $1.25 |
| % of 52W HighCurrent price vs 52-week peak | +92.6% | +40.2% |
| RSI (14)Momentum oscillator 0–100 | 78.5 | 69.1 |
| Avg Volume (50D)Average daily shares traded | 0 | 18.5M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
BTBT is the only dividend payer here at 0.31% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $5.00 |
| # AnalystsCovering analysts | — | 2 |
| Dividend YieldAnnual dividend ÷ price | — | +0.3% |
| Dividend StreakConsecutive years of raises | — | 0 |
| Dividend / ShareAnnual DPS | — | $0.01 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
MCTA leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). BTBT leads in 1 (Valuation Metrics).
MCTA vs BTBT: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is MCTA or BTBT a better buy right now?
For growth investors, Bit Digital, Inc.
(BTBT) is the stronger pick with 264. 6% revenue growth year-over-year, versus 3. 4% for Charming Medical Limited Class A Ordinary Shares (MCTA). Bit Digital, Inc. (BTBT) offers the better valuation at 9. 2x trailing P/E, making it the more compelling value choice. Analysts rate Bit Digital, Inc. (BTBT) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — MCTA or BTBT?
On trailing P/E, Bit Digital, Inc.
(BTBT) is the cheapest at 9. 2x versus Charming Medical Limited Class A Ordinary Shares at 414. 5x.
03Which is the better long-term investment — MCTA or BTBT?
Over the past 5 years, Charming Medical Limited Class A Ordinary Shares (MCTA) delivered a total return of +319.
3%, compared to -84. 6% for Bit Digital, Inc. (BTBT). Over 10 years, the gap is even starker: MCTA returned +319. 3% versus BTBT's -60. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — MCTA or BTBT?
On balance sheet safety, Bit Digital, Inc.
(BTBT) carries a lower debt/equity ratio of 3% versus 24% for Charming Medical Limited Class A Ordinary Shares — giving it more financial flexibility in a downturn.
05Which is growing faster — MCTA or BTBT?
By revenue growth (latest reported year), Bit Digital, Inc.
(BTBT) is pulling ahead at 264. 6% versus 3. 4% for Charming Medical Limited Class A Ordinary Shares (MCTA). On earnings-per-share growth, the picture is similar: Bit Digital, Inc. grew EPS 225. 0% year-over-year, compared to 54. 2% for Charming Medical Limited Class A Ordinary Shares. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — MCTA or BTBT?
Charming Medical Limited Class A Ordinary Shares (MCTA) is the more profitable company, earning 19.
3% net margin versus 17. 3% for Bit Digital, Inc. — meaning it keeps 19. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MCTA leads at 22. 3% versus 16. 8% for BTBT. At the gross margin level — before operating expenses — MCTA leads at 67. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Which pays a better dividend — MCTA or BTBT?
In this comparison, BTBT (0.
3% yield) pays a dividend. MCTA does not pay a meaningful dividend and should not be held primarily for income.
08Is MCTA or BTBT better for a retirement portfolio?
For long-horizon retirement investors, Charming Medical Limited Class A Ordinary Shares (MCTA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+319.
3% 10Y return). Bit Digital, Inc. (BTBT) carries a higher beta of 3. 37 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MCTA: +319. 3%, BTBT: -60. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between MCTA and BTBT?
These companies operate in different sectors (MCTA (Healthcare) and BTBT (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: MCTA is a small-cap quality compounder stock; BTBT is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.